Screener
LB Pharmaceuticals Inc LBRX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets, net | 2,101 | 2,151 |
| Property and equipment, net | 1,531 | 1,581 |
| Restricted cash | 776 | 770 |
| Total assets | $393,482 | $312,934 |
| Liabilities and stockholders’ equity | ||
| Current liabilities | ||
| Accounts payable | $7,119 | $2,127 |
| Accrued expenses | 3,057 | 4,585 |
Item 1. Financial Statements
FAQ
- What is LB Pharmaceuticals Inc's total assets?
- LB Pharmaceuticals Inc (LBRX) reported total assets of $393.48M in Q1 2026.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about LB Pharmaceuticals Inc's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude